Literature DB >> 25616515

Attention Deficit Hyperactivity Disorder symptoms and smoking trajectories: race and gender differences.

Chien-Ti Lee1, Trenette T Clark2, Scott H Kollins3, F Joseph McClernon3, Bernard F Fuemmeler4.   

Abstract

PURPOSE: This study examined the influence of Attention Deficit Hyperactivity Disorder (ADHD) symptoms severity and directionality (hyperactive-impulsive symptoms relative to inattentive symptoms) on trajectories of the probability of current (past month) smoking and the number of cigarettes smoked from age 13 to 32. Racial and gender differences in the relationship of ADHD symptoms and smoking trajectories were also assessed.
METHODS: A subsample of 9719 youth (54.5% female) was drawn from the National Longitudinal Study of Adolescent to Adult Health (Add Health). Cohort sequential design and zero-inflated Poisson (ZIP) latent growth modeling were used to estimate the relationship between ADHD directionality and severity on smoking development.
RESULTS: ADHD severity's effect on the likelihood of ever smoking cigarettes at the intercept (age 13) had a greater impact on White males than other groups. ADHD severity also had a stronger influence on the initial number of cigarettes smoked at age 13 among Hispanic participants. The relationships between ADHD directionality (hyperactive-impulsive symptoms relative to inattentive symptoms) and a higher number of cigarettes smoked at the intercept were stronger among Hispanic males than others. Gender differences manifested only among Whites.
CONCLUSION: ADHD severity and directionality had unique effects on smoking trajectories. Our results also highlight that the risk of ADHD symptoms may differ by race and gender.
Copyright © 2015 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  ADHD symptoms; Racial and gender differences; Smoking trajectories

Mesh:

Year:  2015        PMID: 25616515      PMCID: PMC4437797          DOI: 10.1016/j.drugalcdep.2015.01.002

Source DB:  PubMed          Journal:  Drug Alcohol Depend        ISSN: 0376-8716            Impact factor:   4.492


  33 in total

1.  Sex differences in shared genetic and environmental influences between conduct disorder symptoms and marijuana use in adolescents.

Authors:  Donna R Miles; Marianne B M van den Bree; Roy W Pickens
Journal:  Am J Med Genet       Date:  2002-03-08

Review 2.  Community studies on adolescent substance use, abuse, or dependence and psychiatric comorbidity.

Authors:  Tonya D Armstrong; E Jane Costello
Journal:  J Consult Clin Psychol       Date:  2002-12

3.  Which adolescent experimenters progress to established smoking in the United States.

Authors:  W S Choi; J P Pierce; E A Gilpin; A J Farkas; C C Berry
Journal:  Am J Prev Med       Date:  1997 Sep-Oct       Impact factor: 5.043

4.  Accuracy of adult recall of childhood attention deficit hyperactivity disorder.

Authors:  Salvatore Mannuzza; Rachel G Klein; Donald F Klein; Abrah Bessler; Patrick Shrout
Journal:  Am J Psychiatry       Date:  2002-11       Impact factor: 18.112

5.  Patterns of comorbidity associated with subtypes of attention-deficit/hyperactivity disorder among 6- to 12-year-old children.

Authors:  R B Eiraldi; T J Power; C M Nezu
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  1997-04       Impact factor: 8.829

6.  Representativeness of clinical samples of youths with mental disorders: a preliminary population-based study.

Authors:  S H Goodman; B B Lahey; B Fielding; M Dulcan; W Narrow; D Regier
Journal:  J Abnorm Psychol       Date:  1997-02

7.  Protecting adolescents from harm. Findings from the National Longitudinal Study on Adolescent Health.

Authors:  M D Resnick; P S Bearman; R W Blum; K E Bauman; K M Harris; J Jones; J Tabor; T Beuhring; R E Sieving; M Shew; M Ireland; L H Bearinger; J R Udry
Journal:  JAMA       Date:  1997-09-10       Impact factor: 56.272

8.  Which aspects of ADHD are associated with tobacco use in early adolescence?

Authors:  J D Burke; R Loeber; B B Lahey
Journal:  J Child Psychol Psychiatry       Date:  2001-05       Impact factor: 8.982

9.  Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents.

Authors:  Kenneth P Tercyak; Caryn Lerman; Janet Audrain
Journal:  J Am Acad Child Adolesc Psychiatry       Date:  2002-07       Impact factor: 8.829

10.  Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD.

Authors:  Brooke S G Molina; William E Pelham
Journal:  J Abnorm Psychol       Date:  2003-08
View more
  4 in total

1.  Sex and racial/ethnic differences in the association between childhood attention-deficit/hyperactivity disorder symptom subtypes and body mass index in the transition from adolescence to adulthood in the United States.

Authors:  Y Inoue; A G Howard; A Stickley; A Yazawa; P Gordon-Larsen
Journal:  Pediatr Obes       Date:  2019-01-10       Impact factor: 4.000

2.  Childhood attention-deficit/hyperactivity disorder symptoms and the development of adolescent alcohol problems: A prospective, population-based study of Swedish twins.

Authors:  Patrick D Quinn; Erik Pettersson; Sebastian Lundström; Henrik Anckarsäter; Niklas Långström; Clara Hellner Gumpert; Henrik Larsson; Paul Lichtenstein; Brian M D'Onofrio
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2015-12-30       Impact factor: 3.568

Review 3.  Sex Differences in Substance Use, Prevalence, Pharmacological Therapy, and Mental Health in Adolescents with Attention-Deficit/Hyperactivity Disorder (ADHD).

Authors:  Francisca Castellano-García; Ana Benito; Antonio Jovani; Alejandro Fuertes-Sáiz; María Isabel Marí-Sanmillán; Gonzalo Haro
Journal:  Brain Sci       Date:  2022-05-02

4.  Substance use in childhood and adolescence and its associations with quality of life and behavioral strengths and difficulties.

Authors:  Wiebke Frobel; Nico Grafe; Christof Meigen; Mandy Vogel; Andreas Hiemisch; Wieland Kiess; Tanja Poulain
Journal:  BMC Public Health       Date:  2022-02-10       Impact factor: 3.295

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.